WuXi AppTec, WuXi Biologics surge in Hong Kong as biotech firms put some operations for sale

SCMP | Oct. 4, 2024, 6 a.m. | Original
The gains were made on the back of a report that said the two firms plan to sell certain overseas operations amid heightened US scrutiny.
Thailand’s poorest hail costly cash handout scheme - ‘we can breathe’ Hong Kong can’t rest on laurels once it overtakes Switzerland as top family office hub: official